SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Landec Corporation on February 20, 2003. The filing addresses a corporate governance decision regarding the company's fiscal calendar. Note: The input metadata references "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as "LANDEC CORPORATION".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly procedural and contains no financial performance data.
Material Changes
- Fiscal Year Change: The Board of Directors approved a change in the fiscal year end date.
- Previous Fiscal Year: Ended on the last Sunday in October (52 or 53 weeks).
- New Fiscal Year: Will end on the last Sunday in May (52 or 53 weeks).
- Transition Reporting: The company will file a transition report on Form 10-K covering the seven-month period ended May 25, 2003.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document is limited to the announcement of the fiscal year change.
Investor Verification Checklist
- Verify the upcoming Form 10-K transition report for the seven-month period ending May 25, 2003.
- Confirm the impact of the fiscal year change on future quarterly reporting schedules.
- Review subsequent filings to ensure the new fiscal year end (last Sunday in May) is consistently applied.